Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Identification potential inhibitors against the Streptococcus quorum-sensing signal pathway.

Long X, Zheng R, Liu M, Wu C, Bao J.

J Biomol Struct Dyn. 2019 Aug 14:1-11. doi: 10.1080/07391102.2019.1651674. [Epub ahead of print]

PMID:
31378148
2.

Analyses of artificial morel soil bacterial community structure and mineral element contents in ascocarp and the cultivated soil.

Zhang F, Long L, Hu Z, Yu X, Liu Q, Bao J, Long Z.

Can J Microbiol. 2019 Jun 17:1-12. doi: 10.1139/cjm-2018-0600. [Epub ahead of print]

PMID:
31206319
3.

Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach.

Yuan Y, Hu Z, Bao M, Sun R, Long X, Long L, Li J, Wu C, Bao J.

J Biomol Struct Dyn. 2019 Sep;37(15):4092-4103. doi: 10.1080/07391102.2018.1541141. Epub 2018 Dec 5.

PMID:
30417746
4.

Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma.

Zhong L, Zhou S, Tong R, Shi J, Bai L, Zhu Y, Duan X, Liu W, Bao J, Su L, Peng Q.

Invest New Drugs. 2019 Aug;37(4):616-624. doi: 10.1007/s10637-018-0651-4. Epub 2018 Aug 31.

PMID:
30168013
5.

Computer-aided identification of a novel pyruvate kinase M2 activator compound.

Li Y, Bao M, Yang C, Chen J, Zhou S, Sun R, Wu C, Li X, Bao J.

Cell Prolif. 2018 Dec;51(6):e12509. doi: 10.1111/cpr.12509. Epub 2018 Aug 21.

PMID:
30133040
6.
7.

Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.

Lu K, Wang X, Chen Y, Liang D, Luo H, Long L, Hu Z, Bao J.

Acta Biochim Biophys Sin (Shanghai). 2018 May 1;50(5):456-464. doi: 10.1093/abbs/gmx142.

PMID:
29546355
8.

Antifungal activity, main active components and mechanism of Curcuma longa extract against Fusarium graminearum.

Chen C, Long L, Zhang F, Chen Q, Chen C, Yu X, Liu Q, Bao J, Long Z.

PLoS One. 2018 Mar 15;13(3):e0194284. doi: 10.1371/journal.pone.0194284. eCollection 2018.

9.

In silico identification of small molecules as novel LXR agonists for the treatment of cardiovascular disease and cancer.

Wang X, Lu K, Luo H, Liang D, Long X, Yuan Y, Wu C, Bao J.

J Mol Model. 2018 Feb 15;24(3):57. doi: 10.1007/s00894-018-3578-y.

PMID:
29450657
10.

Novel pogostone analogous XW-12-loading nanoparticles display enhanced systematic activity against methicillin-resistant Staphylococcus aureus.

Wang X, Wu F, Chen Y, Qin F, Bao J, Chen G.

J Microencapsul. 2018 Jan;35(1):78-89. doi: 10.1080/02652048.2018.1425751. Epub 2018 Jan 24.

PMID:
29308688
11.

CM-viewer: Visualizing interaction network of co-mutated and mutually exclusively mutated cancer genes.

Zhou N, Hu Z, Wu C, Bao J.

Biosystems. 2018 Apr;166:37-42. doi: 10.1016/j.biosystems.2017.12.009. Epub 2017 Dec 24.

PMID:
29278730
12.

Structure and function analysis of Polygonatum cyrtonema lectin by site-directed mutagenesis.

Chen Y, Lu K, Li J, Liang D, Luo H, Wang X, Wang X, Bao J.

Acta Biochim Biophys Sin (Shanghai). 2017 Dec 1;49(12):1099-1111. doi: 10.1093/abbs/gmx116.

PMID:
29121159
13.

Mutational signatures efficiently identify different mutational processes underlying cancers with similar somatic mutation spectra.

Zhou N, Yuan Y, Long X, Wu C, Bao J.

Mutat Res. 2017 Dec;806:27-30. doi: 10.1016/j.mrfmmm.2017.07.004. Epub 2017 Jul 19.

PMID:
28942182
14.

L1198F Mutation Resensitizes Crizotinib to ALK by Altering the Conformation of Inhibitor and ATP Binding Sites.

Li J, Sun R, Wu Y, Song M, Li J, Yang Q, Chen X, Bao J, Zhao Q.

Int J Mol Sci. 2017 Feb 24;18(3). pii: E482. doi: 10.3390/ijms18030482.

15.

Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.

Jiang W, Li X, Li T, Wang H, Shi W, Qi P, Li C, Chen J, Bao J, Huang G, Wang Y.

Int J Oncol. 2017 Mar;50(3):823-834. doi: 10.3892/ijo.2017.3860. Epub 2017 Jan 24.

PMID:
28197631
16.

Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma.

Xu X, Liu C, Bao J.

Mol Med Rep. 2017 Mar;15(3):1373-1378. doi: 10.3892/mmr.2017.6139. Epub 2017 Jan 24.

PMID:
28138701
17.

Insight into drug resistance mechanisms and discovery of potential inhibitors against wild-type and L1196M mutant ALK from FDA-approved drugs.

Li J, Liu W, Luo H, Bao J.

J Mol Model. 2016 Sep;22(9):231. doi: 10.1007/s00894-016-3099-5. Epub 2016 Sep 1.

PMID:
27585676
18.

Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway.

Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, Tian W.

Mol Med Rep. 2016 Sep;14(3):1891-900. doi: 10.3892/mmr.2016.5508. Epub 2016 Jul 12.

19.

Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer.

Li J, Wang H, Li J, Bao J, Wu C.

Int J Mol Sci. 2016 Jul 1;17(7). pii: E1055. doi: 10.3390/ijms17071055.

20.

Role of reactive oxygen species-mediated MAPK and NF-κB activation in polygonatum cyrtonema lectin-induced apoptosis and autophagy in human lung adenocarcinoma A549 cells.

Liu T, Wu L, Wang D, Wang H, Chen J, Yang C, Bao J, Wu C.

J Biochem. 2016 Dec;160(6):315-324. Epub 2016 Jun 18.

PMID:
27318358

Supplemental Content

Loading ...
Support Center